CHWY
Chewy, Inc.
CHWY
Chewy, Inc.
Chewy delivered strong EBITDA and better-than-expected Q2 results, driven by organic sales growth and an expanding customer base. CHWY's strategic expansion into new verticals, notably veterinary care
Anthropic (ANTHRO) faces internal and external warnings about catastrophic AI risks, with no clear alignment solution for superintelligence in sight. Meta Platforms (META) surges on the launch of AI a
Chewy, Inc. (NYSE:CHWY) will release its second earnings report before the opening bell on Wednesday, Sept. 9.
This week's market focus is the August CPI report, which could determine a September Fed rate hike. A hot inflation print may cement a rate hike, with current odds at 60% following strong payroll data
Wall Street's major averages declined this week after a continuous sell-off in semiconductor stocks rattled the markets, while tensions in the Middle East persisted
Chewy remains a Strong Buy, with valuation implying a high margin of safety even under conservative assumptions and challenging macro conditions. Q1 delivered 7.7% YoY net sales growth, $71M FCF, reco
Chewy NYSE: CHWY held its 2026 Annual Meeting of Stockholders, with Chairman of the Board Raymond Svider presiding over the virtual meeting and announcing preliminary voting results on four proposals.
Chewy remains a "Buy" despite a 40% YTD decline and a guidance cut, as I view challenges as cyclical, not structural. CHWY lowered FY26 sales outlook to $13.40–$13.55 billion, citing macro headwinds